Abstract
Durable Response to Nivolumab in a Patient With Hepatic Sarcomatoid Carcinoma: Evolutive Characterization of Genomic and Immunohistochemical PD-L1 Expression Findings.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have